Company eyes clinical trials of mRNA therapy targeting intracellular free cholesterol after receiving ‘favorable’ pre-IND feedback.
Company eyes clinical trials of mRNA therapy targeting intracellular free cholesterol after receiving ‘favorable’ pre-IND feedback.
Comments are closed.